Name: Auscann Group Holdings (AC8) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

AC8

Pharmaceuticals, Biotechnology & Life Sciences

Auscann Group Holdings

Short interest: 0.01%; 0.00 pp 30d; as of 21 Feb 2022
Reported shorts: 50.9K
Shares on issue: 440.547M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Auscann Group Holdings

AusCann Group Holdings Ltd focuses on the cultivation, manufacture, and supply of medical cannabis products. The company aims to provide high-quality, standardized cannabis-based medicines to improve patient outcomes. With a focus on research and development, AusCann seeks to establish itself as a leader in the Australian medical cannabis market.

Company profile →

Auscann Group Holdings (ASX:AC8) has 0.01% of its shares on issue reported as short positions as of 21 Feb 2022, or about 50,867 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.78% in May 2017. AC8 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.